Navigation Links
Penn Medicine's Daniel J. Rader, M.D., receives AHA's Clinical Research Prize
Date:11/5/2012

LOS ANGELES - Daniel J. Rader, MD, professor of Medicine and chief, Division of Translational Medicine and Human Genetics at the Perelman School of Medicine at the University of Pennsylvania, has been awarded the American Heart Association's (AHA) Clinical Research Prize for developing new methods to identify factors regulating the metabolism of fat particles in the bloodstream and testing their impact on the development of atherosclerosis. Dr. Rader received the award today during the opening ceremony of the AHA Scientific Sessions in Los Angeles, CA.

Dr. Rader has spent the last two decades working in the field of lipoprotein biology and atherosclerosis, and is a widely recognized international leader in this field. His basic research laboratory focuses on genetic and pharmacologic regulation of lipoprotein metabolism and atherosclerosis, and he directs a translational research program focusing on new pathways involved in lipoprotein metabolism and atherosclerosis discovered through human genetics studies and novel approaches to treatment of dyslipidemia and atherosclerotic cardiovascular disease.

Dr. Rader has a particular interest in the metabolism of HDL (the "good cholesterol") and its relationship to atherosclerosis. In recent research, he has illuminated pathways of HDL-mediated 'reverse cholesterol transport' and has shown that the functional ability of HDL to extract cholesterol from cells is a better predictor of coronary disease than HDL cholesterol blood levels. In addition, Rader and his team have helped to understand how new genes associated with dyslipidemia and coronary artery disease work to influence these conditions. Finally, Rader and his team demonstrated the potential usefulness of a drug that works through a new pathway to lower LDL (the "bad cholesterol") in patients with a severe form of inherited high cholesterol.

He is a Distinguished Fellow of the International Atherosclerosis Society, a member of the Board of External Experts of the National Heart, Lung, and Blood Institute (NHLBI), and a member of the Institute of Medicine.


'/>"/>
Contact: Jessica Mikulski
jessica.mikulski@uphs.upenn.edu
215-796-4829
University of Pennsylvania School of Medicine
Source:Eurekalert

Related medicine news :

1. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
2. DNA Testing Finds Allergens, Toxins in Traditional Chinese Medicines
3. Not taking gastroprotective drugs prescribed with anti-inflammatory medicines
4. Nearly 1 in 4 grandparents store prescription medicines where children can easily find them
5. Nanomedicines promise fewer side effects in treating cancer
6. New technology represents next-generation tool for detecting substandard and counterfeit medicines
7. New research reveals extent of poor-quality antimalarial medicines in South American countries
8. Toward medicines that recruit the bodys natural disease-fighting proteins
9. Strategy developed to improve delivery of medicines to the brain
10. Popular pain-relieving medicines linked to hearing loss in women
11. Edith Mitchell, M.D., FACP, named 2012 recipient of ASCO Humanitarian Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent Care ... MD Now’s 28th facility overall and marks the urgent care center's eighth location in ... North of The Falls shopping mall. The new clinic offers a wide array of ...
(Date:6/23/2017)... ... ... American Farmer, will feature Chr. Hansen, Inc (CHR Hansen) in an upcoming episode ... Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your local listings for more info. ... 1874 after a groundbreaking discovery of how to industrialize enzymes. Rooted in science and ...
(Date:6/23/2017)... Chicago, IL (PRWEB) , ... June 23, 2017 ... ... insurance management assistance and financial planning services to communities in the greater Chicago ... Children’s Association to offer assistance to underprivileged youth in Chicago. , Founded in ...
(Date:6/23/2017)... ... June 23, 2017 , ... Moore Insurance, ... area with access to asset protection and financial planning services, is teaming up ... improving the lives of children with cancer and other chronic diseases. , The ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... is pleased to welcome Whipple & Company as its newest Partner Firm. Headquartered ... of balancing their clients’ risk while tailoring optimized benefit packages that strengthen the ...
Breaking Medicine News(10 mins):
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... Israel, May 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... technology which enables the functional selection of stem cells, ... for the first quarter ended March 31 st , ... our accomplishments in the first quarter of 2017," said ... quarter, we announced the treatment of the first blood ...
(Date:5/22/2017)... VALLEY COTTAGE, N.Y. , May 22, 2017 ... natural antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of ... in plain English, the results of a clinical ... after one year treatment with Gene-Eden-VIR/Novirin in individuals ... is important to note that there are no ...
Breaking Medicine Technology: